August 11, 2011
GlaxoSmithKline PLC on Wednesday prevailed in a suit alleging it falsely marked the laxative Citrucel with expired patents, with a New York federal judge ruling following a bench trial that there was no evidence the company knew the patents were expired or intended to deceive the public.
March 25, 2011
A New York federal judge ruled Tuesday that the false marking statute is constitutional, rejecting a bid by GlaxoSmithKline PLC to dismiss a suit that claims the company marked its laxative Citrucel with expired patents.